<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741635</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-190</org_study_id>
    <nct_id>NCT02741635</nct_id>
  </id_info>
  <brief_title>The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ</brief_title>
  <official_title>The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed to evaluate the performance (leak and comfort) as well as the
      participant's overall acceptance of the nasal pillows mask amongst Obstructive Sleep Apnea
      (OSA) participants. Also to assist in the development process it would be beneficial to get
      feedback from users on certain aspects of the design. The aim of this investigation is to get
      feedback on the first impressions (look and feel) from users of nasal pillows PAP therapy.

      A total number of 15 participants who currently use a nasal pillows mask will be recruited
      for the trial. Participants from previous NZ trials may be recruited into this trial with
      their consent. All the participants will be recruited from the Fisher &amp; Paykel Healthcare
      Database of subjects with OSA (Ethics Reference NTY/08/06/064), Auckland District Health
      Board (ADHB) and New Zealand Respiratory and Sleep Institute (NZRSI).

      Participants will undergo an overnight polysomnography session at the Fisher &amp; Paykel
      Healthcare sleep lab.

      The participant will use the trial device on their usual Continuous or Auto Positive Airway
      Pressure (CPAP/APAP) setting and device for the duration of the overnight in-lab study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Initial Impressions of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</measure>
    <time_frame>12 hours</time_frame>
    <description>Participants choose the Toffee mask based on first impressions over 3 market leading masks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</measure>
    <time_frame>12 hours</time_frame>
    <description>Participants consider the Toffee mask to be as comfortable, or much more comfortable than their usual mask.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of the Toffee Nasal Pillows Mask Assessed With Visual Observations</measure>
    <time_frame>12 hours</time_frame>
    <description>Participants consider the Toffee mask to be easier or much easier to fit and adjust than their current mask</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>New Nasal Pillows Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New Nasal Pillows Mask</intervention_name>
    <description>Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
    <arm_group_label>New Nasal Pillows Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (18+ years of age)

          -  Able to give consent

          -  AHI â‰¥ 5 on diagnostic night

          -  Prescribed a CPAP device after successful OSA diagnosis

          -  Existing nasal pillows mask user

        Exclusion Criteria:

          -  Inability to give consent

          -  Patients who are in a coma or a decreased level of consciousness.

          -  Anatomical or physiological conditions making APAP therapy inappropriate

          -  Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)

          -  Current diagnosis of CO2 retention

          -  Pregnant or may think they are pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bhavi Ogra, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sponsor Employee</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fisher &amp; Paykel Healthcare Ltd</name>
      <address>
        <city>Auckland</city>
        <state>East Tamaki</state>
        <zip>2013</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 6, 2016</study_first_submitted>
  <study_first_submitted_qc>April 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <results_first_submitted>May 4, 2020</results_first_submitted>
  <results_first_submitted_qc>May 4, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 15, 2020</results_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>For product development purposes only. Data will be de-identified.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Toffee Nasal Pillows Mask</title>
          <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
New Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Toffee Nasal Pillows Mask</title>
          <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
Toffee Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18+ years of age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Initial Impressions of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</title>
        <description>Participants choose the Toffee mask based on first impressions over 3 market leading masks.</description>
        <time_frame>12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Toffee Nasal Pillows Mask</title>
            <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
New Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
          </group>
        </group_list>
        <measure>
          <title>First Initial Impressions of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</title>
          <description>Participants choose the Toffee mask based on first impressions over 3 market leading masks.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comfort of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</title>
        <description>Participants consider the Toffee mask to be as comfortable, or much more comfortable than their usual mask.</description>
        <time_frame>12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Toffee Nasal Pillows Mask</title>
            <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
New Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire</title>
          <description>Participants consider the Toffee mask to be as comfortable, or much more comfortable than their usual mask.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Usability of the Toffee Nasal Pillows Mask Assessed With Visual Observations</title>
        <description>Participants consider the Toffee mask to be easier or much easier to fit and adjust than their current mask</description>
        <time_frame>12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Toffee Nasal Pillows Mask</title>
            <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
Toffee Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
          </group>
        </group_list>
        <measure>
          <title>Usability of the Toffee Nasal Pillows Mask Assessed With Visual Observations</title>
          <description>Participants consider the Toffee mask to be easier or much easier to fit and adjust than their current mask</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Toffee Nasal Pillows Mask</title>
          <description>Participants to use nasal pillows mask one night in lab overnight polysomnography.
Toffee Nasal Pillows Mask: Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Christine Lambert</name_or_title>
      <organization>Fisher &amp; Paykel Healthcare Ltd.</organization>
      <phone>+64 9 574 0123 ext 7172</phone>
      <email>christine.lambert@fphcare.co.nz</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

